“…These studies cover 28 end points, including several endocrine end points, induction of xenobiotic metabolism, neurotoxicity, phytotoxicity, oxidative stress response, baseline toxicity, as well as genotoxicity and mutagenicity (Tables S7 and S8). ,,,− ,,− By far the best-studied end point is estrogenicity (22 out of 31 studies), followed by genotoxicity (18), mutagenicity (12), phytotoxicity(11), bacterial toxicity (11), androgenicity (11), antiandrogenicity (9), aryl-hydrocarbon receptor (AhR) activity (8), antiestrogenicity (7), as well as acetylcholinesterase (AchE) inhibition (4) and glucocorticoid and thyroid activity (4). For all other end points, only data from less than four studies was available.…”